Hi,  welcome to EN-CPhI.cn  Sign In Join Free For Buyer

Search Inquiry Cart (0)
Chifeng Arker Pharmaceutical Technology Co., Ltd.
Chifeng Arker Pharmaceutical Technology Co., Ltd.
You are here: Home >> Marketing Website>> Company Profile
  • Our Company
  • Year Established: 2000

  • Total Annual Sales(USD): choose not to disclose

  • Total Number of Staff: 200 to 249

  • Main Competitive Advantages:

  • Other Competitive Advantages: We are the earliest and largest manufacturer of Ephedrine and salts.

  • Patents and Copyrights: synthetic Ephedrine process

  • Our Business
  • Business Type: Manufacturer

  • Annual Sales(USD): choose not to disclose

  • Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Major Product Categories: Active Pharmaceutical Ingredients , Intermediates

  • All Products: Ephedrine&Pseudoephedrine salts ,Dirithromycin, Balsalazide Disodium, Phenylephrine Hcl, Ipriflavone, Atenolol, Asarone, Oxyfedrine Hcl, Nifedipine, Chlorothiazide, Zopiclone, Glipizide, Glibenclamide, Nitazoxanide

  • Product Export Percentage: 20

  • Product Domestic Sale Percentage: 80

  • Main Clients' Names: Johnson&Johnson,GSK, Bayer, Wyeth

  • Other Information
  • Contract Manufacturing

  • Payment Terms: T/T in advance , L/C

Company Profile

Chifeng Arker Pharmaceutical Technology Co., Ltd., a former Ephedrine & Pseudoephedrine salts plant of Chifeng Pharmaceutical Co., Ltd., is a leading Chinese Manufacturer of Ephedrine & Pseudoephedrine salts API with over 60 years of production. Nowadays, it's a member of Shanghai Pharmaceuticals Holding Co., Ltd.

The company has passed cGMP compliance inspection by USFDA, KFDA and GMP certification by SFDA, China, and gained CoS/CEP certificates.

Depending on good QA and EHS systems, we are approved suppliers for world-renowned pharmaceutical companies, i.e., GSK, Johnson & Johnson, Bristol-Myers Squibb, Bayer, Pfizer, Novartis, Sandoz, Boehringer Ingelheim, etc.


2000: company Established 2002: GMP certificate from SFDA 2002: passed US-FDA cGMP inspection: 483 not issued 2003: obtained European COS 2004: filed Ephedrine HCl and Pseudoephedrine HCl US DMF as per customer request 2007: GMP certificate from SFDA again 2008: filed Chlorothiazide US DMF 2010:passed US-FDA track inspection

Last Updated: Mar 19, 2018 Add as my favorite supplier Abuse Report Product Alert
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53
live chat